Solution structure of the N-terminal transactivation domain of ERM modified by SUMO-1

Biochemical and Biophysical Research Communications

Volumn 399, Issue 1, 2010, Pages 104-110

  Lens, Zoé ^a,c   Dewitte, Frédérique ^a   Monté, Didier ^a   Baert, Jean Luc ^a   Bompard, Coralie ^a   Sénéchal, Magalie ^b   Van Lint, Carine ^c   de Launoit, Yvan ^b   Villeret, Vincent ^a   Verger, Alexis ^a  

^a CNRS   (France)

^b INSTITUT DE BIOLOGIE DE LILLE   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

ERM; Intrinsically disordered; SAXS; SUMO; Transactivation domain

Indexed keywords

SUMO 1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERM; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; PRIORITY JOURNAL; SUMOYLATION; X RAY CRYSTALLOGRAPHY;

DNA-BINDING PROTEINS; HUMANS; PROTEIN STRUCTURE, TERTIARY; SCATTERING, SMALL ANGLE; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; X-RAY DIFFRACTION;

EID: 77955561331     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.049     Document Type: Article

References (39)

1. Triezenberg S.J. Structure and function of transcriptional activation domains. Curr. Opin. Genet. Dev. 1995, 5:190-196.
2. Dyson H.J., Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6:197-208.
3. Di Lello P., Jenkins L.M., Jones T.N., Nguyen B.D., Hara T., Yamaguchi H., Dikeakos J.D., Appella E., Legault P., Omichinski J.G. Structure of the Tfb1/p53 complex: insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol. Cell 2006, 22:731-740.
4. Uesugi M., Nyanguile O., Lu H., Levine A.J., Verdine G.L. Induced alpha helix in the VP16 activation domain upon binding to a human TAF. Science 1997, 277:1310-1313.
5. Monté D., Baert J.L., Defossez P.A., de Launoit Y., Stéhelin D. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. Oncogene 1994, 9.
6. de Launoit Y., Baert J.L., Chotteau-Lelievre A., Monte D., Coutte L., Mauen S., Firlej V., Degerny C., Verreman K. The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis. Biochim. Biophys. Acta 2006, 1766:79-87.
7. Defossez P.A., Baert J.L., Monnot M., de Launoit Y. The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60. Nucleic Acids Res. 1997, 25:4455-4463.
8. Laget M.P., Defossez P.A., Albagli O., Baert J.L., Dewitte F., Stéhelin D., de Launoit Y. Two functionally distinct domains responsible for transactivation by the Ets family member ERM. Oncogene 1996, 12:1325-1336.
9. Mauen S., Huvent I., Raussens V., Demonte D., Baert J.L., Tricot C., Ruysschaert J.M., Van Lint C., Moguilevsky N., de Launoit Y. Expression, purification, and structural prediction of the Ets transcription factor ERM. Biochim. Biophys. Acta 2006, 1760:1192-1201.
10. Degerny C., de Launoit Y., Baert J.L. ERM transcription factor contains an inhibitory domain which functions in sumoylation-dependent manner. Biochim. Biophys. Acta 2008, 1779:183-194.
11. Degerny C., Monte D., Beaudoin C., Jaffray E., Portois L., Hay R.T., de Launoit Y., Baert J.L. SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity. J. Biol. Chem. 2005, 280:24330-24338.
12. Iakoucheva L.M., Brown C.J., Lawson J.D., Obradovic Z., Dunker A.K. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 2002, 323:573-584.
13. Putnam C.D., Hammel M., Hura G.L., Tainer J.A. X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. Q. Rev. Biophys. 2007, 40:191-285.
14. Uchimura Y., Nakao M., Saitoh H. Generation of SUMO-1 modified proteins in E. coli: towards understanding the biochemistry/structural biology of the SUMO-1 pathway. FEBS Lett. 2004, 564:85-90.
15. Romero P., Obradovic Z., Li X., Garner E.C., Brown C.J., Dunker A.K. Sequence complexity of disordered protein. Proteins 2001, 42:38-48.
16. Uversky V.N. What does it mean to be natively unfolded?. Eur. J. Biochem. 2002, 269:2-12.
17. Konarev P.V., Volkov V.V., Sokolova A.V., Koch M.H., Svergun D. PRIMUS - a Windows-PC based system for small-angle scattering data analysis. J. Appl. Crystallogr. 2003, 36:1277-1282.
18. Svergun D.I. Determination of the regularization parameter in indirect transform methods using perceptual criteria. J. Appl. Crystallogr. 1992, 25:495-503.
19. Svergun D.I., Petoukhov M.V., Koch M.H. Determination of domain structure of proteins from X-ray solution scattering. Biophys. J. 2001, 80:2946-2953.
20. Volkov V.V., Svergun D.I. Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Crystallogr. 2003, 2003:860-864.
21. Bourhis J.M., Receveur-Brechot V., Oglesbee M., Zhang X., Buccellato M., Darbon H., Canard B., Finet S., Longhi S. The intrinsically disordered C-terminal domain of the measles virus nucleoprotein interacts with the C-terminal domain of the phosphoprotein via two distinct sites and remains predominantly unfolded. Protein Sci. 2005, 14:1975-1992.
22. Bressan G.C., Silva J.C., Borges J.C., Dos Passos D.O., Ramos C.H., Torriani I.L., Kobarg J. Human regulatory protein Ki-1/57 has characteristics of an intrinsically unstructured protein. J. Proteome Res. 2008, 7:4465-4474.
23. Nardini M., Svergun D., Konarev P.V., Spano S., Fasano M., Bracco C., Pesce A., Donadini A., Cericola C., Secundo F., Luini A., Corda D., Bolognesi M. The C-terminal domain of the transcriptional co-repressor CtBP is intrinsically unstructured. Protein Sci. 2006, 15:1042-1050.
24. Bayer P., Arndt A., Metzger S., Mahajan R., Melchior F., Jaenicke R., Becker J. Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 1998, 280:275-286.
25. Campbell K.M., Terrell A.R., Laybourn P.J., Lumb K.J. Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos. Biochemistry 2000, 39:2708-2713.
26. Wells M., Tidow H., Rutherford T.J., Markwick P., Jensen M.R., Mylonas E., Svergun D.I., Blackledge M., Fersht A.R. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proc. Natl. Acad. Sci. USA 2008, 105:5762-5767.
27. Yoon M.K., Shin J., Choi G., Choi B.S. Intrinsically unstructured N-terminal domain of bZIP transcription factor HY5. Proteins 2006, 65:856-866.
28. Liu J., Perumal N.B., Oldfield C.J., Su E.W., Uversky V.N., Dunker A.K. Intrinsic disorder in transcription factors. Biochemistry 2006, 45:6873-6888.
29. Minezaki Y., Homma K., Kinjo A.R., Nishikawa K. Human transcription factors contain a high fraction of intrinsically disordered regions essential for transcriptional regulation. J. Mol. Biol. 2006, 359:1137-1149.
30. Nakae K., Nakajima K., Inazawa J., Kitaoka T., Hirano T. ERM, a PEA3 subfamily of Ets transcription factors, can cooperate with c-Jun. J. Biol. Chem. 1995, 270:23795-23800.
31. Schneikert J., Peterziel H., Defossez P.A., Klocker H., Launoit Y., Cato A.C. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J. Biol. Chem. 1996, 271:23907-23913.
32. Pastorcic M., Das H.K. The C-terminal region of CHD3/ZFH interacts with the CIDD region of the Ets transcription factor ERM and represses transcription of the human presenilin 1 gene. FEBS J. 2007, 274:1434-1448.
33. Pastorcic M., Das H.K. Analysis of transcriptional modulation of the presenilin 1 gene promoter by ZNF237, a candidate binding partner of the Ets transcription factor ERM. Brain Res. 2007, 1128:21-32.
34. Baba D., Maita N., Jee J.G., Uchimura Y., Saitoh H., Sugasawa K., Hanaoka F., Tochio H., Hiroaki H., Shirakawa M. Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature 2005, 435:979-982.
35. Macauley M.S., Errington W.J., Scharpf M., Mackereth C.D., Blaszczak A.G., Graves B.J., McIntosh L.P. Beads-on-a-string, characterization of ETS-1 sumoylated within its flexible N-terminal sequence. J. Biol. Chem. 2006, 281:4164-4172.
36. Macauley M.S., Errington W.J., Okon M., Scharpf M., Mackereth C.D., Schulman B.A., McIntosh L.P. Structural and dynamic independence of isopeptide-linked RanGAP1 and SUMO-1. J. Biol. Chem. 2004, 279:49131-49137.
37. Pichler A., Knipscheer P., Oberhofer E., van Dijk W.J., Korner R., Olsen J.V., Jentsch S., Melchior F., Sixma T.K. SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat. Struct. Mol. Biol. 2005, 12:264-269.
38. Tateishi Y., Ariyoshi M., Igarashi R., Hara H., Mizuguchi K., Seto A., Nakai A., Kokubo T., Tochio H., Shirakawa M. Molecular basis for SUMOylation-dependent regulation of DNA binding activity of heat shock factor 2. J. Biol. Chem. 2009, 284:2435-2447.
39. Kim J., Sharma S., Li Y., Cobos E., Palvimo J.J., Williams S.C. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins. J. Biol. Chem. 2005, 280:12246-12254.